The following government grants in the FederalGrants.com database contain the term small business in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
Grant Title | CFDA | Funding Number |
Supporting the provision of person-centered, equitable, high-quality, and integrated service delivery towards a sustainable and resilient HIV/TB response in the Kingdom of Eswatini under PEPFAR |
93.067 |
CDC-RFA-JG-25-0074 |
Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional) |
93.399 |
RFA-CA-25-019 |
Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) |
93.172 |
RFA-HG-25-009 |
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed) |
93.395 |
PAR-25-336 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-25-002 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-25-004 |
NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional) |
93.173 |
RFA-DC-25-002 |
Continuation of the NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed) |
93.847 |
RFA-DK-25-023 |
Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
93.233, 93.837, 93.838, 93.839, 93.840 |
RFA-HL-25-011 |
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Individuals, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional) |
93.313, 93.865 |
PAR-25-311 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-25-001 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) |
93.394 |
RFA-CA-25-003 |
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional) |
93.279 |
PAS-25-236 |
2025 Academy for Women Entrepreneurs Canada (AWE) |
19.022 |
PD-FY25-CANADA-AWE |
Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances |
93.084 |
RFA-PS-25-113 |
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) |
93.393 |
PAR-25-325 |
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) |
93.273, 93.307, 93.310, 93.313, 93.361, 93.399 |
PAR-25-317 |
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required) |
93.213, 93.273, 93.307, 93.361 |
RFA-AA-24-012 |
Coastal Habitat Restoration and Resilience Grants for Tribes and Underserved Communities, Under the BIL Round 3 |
11.463 |
NOAA-NMFS-HCPO-2025-29689 |
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) |
93.866 |
PAR-25-247 |
PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention |
93.084 |
RFA-PS-25-112 |
Black Lung Clinics Program |
93.965 |
HRSA-25-040 |
Black Lung Data and Resource Center |
93.965 |
HRSA-25-039 |
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional) |
93.113, 93.273, 93.361, 93.846 |
RFA-NR-25-003 |
Neutralization In Challenging Environments Using Lethal Effects (NICELE) |
12.300 |
N0001425SBC02 |
Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-24-080 |
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-25-029 |
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) |
93.350 |
PAR-25-155 |
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-25-028 |
Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-25-001 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) |
93.121, 93.393, 93.394, 93.395, 93.396, 93.399 |
PAR-25-346 |
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed) |
93.121, 93.213, 93.273, 93.279, 93.350, 93.846, 93.853, 93.865, 93.866 |
PAR-25-154 |
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) |
93.847 |
PAR-25-277 |
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) |
93.866 |
PAR-25-224 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
93.393, 93.394, 93.395, 93.396, 93.399 |
PAR-25-321 |
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) |
93.350 |
PAR-25-157 |
Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed) |
93.172 |
PAR-25-309 |
Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional) |
93.310 |
RFA-RM-24-010 |
Small Business Informatics Tools for the Pangenome (R43 Clinical Trial Not Allowed) |
93.172 |
PAR-25-308 |
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed) |
93.121 |
PAR-25-045 |
Search Results 201-240 of 22029 [Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 [Next] |